XIIlab Co. Ltd. (189330.KQ) stock: key figures, P/E, revenue and dividend
Information Technology · Application Software · South Korea
XIIlab Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 9.09 bn KRW | 10.27 bn KRW |
| Gross profit | 1.31 bn KRW | 2.44 bn KRW |
| Operating income | -5.28 bn KRW | -3.23 bn KRW |
| EBIT | -5.10 bn KRW | -3.07 bn KRW |
| Net income | -5.19 bn KRW | -3.12 bn KRW |
| Diluted EPS – continuing operations | -750.51 KRW | -332.46 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About XIIlab Co. Ltd.
XIIlab Co.,Ltd provides data-driven AI video analysis services in South Korea. It offers X-AIVA, an AI video analysis platform; Uyuni, an AI standard platform based on Kubenetes; X-Labeller, a video data processing solution; X-GEN, a synthetic data generation solution; and Vidigo, a cloud-based AI video and speech analysis service. The company was founded in 2010 and is headquartered in Seoul, South Korea.
More stocks
- Aura Energy Ltd (AEE.AX)
- LumenRadio AB (LUMEN.ST)
- Rubicon Technology Inc (RBCN)
- OSE Pharma SA (OSE.PA)
- Ildong Holdings Co Ltd (000230.KS)
- Empresas la Polar SA (ABC.SN)
- Marpai, Inc. (MRAI)
- Sibek AB (publ) (SIBEK.ST)
- Mospec Semiconductor Corp (2434.TW)
- ONCOLYTICS BIOTECH INC (ONCY)
- Charlotte's Web Holdings, Inc. (CWBHF)
- RenovoRx, Inc. (RNXT)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.